Cargando…
Addressing the Cold Reality of mRNA Vaccine Stability
As mRNA vaccines became the frontrunners in late-stage clinical trials to fight the COVID-19 pandemic, challenges surrounding their formulation and stability became readily apparent. In this commentary, we first describe company proposals, based on available public information, for the (frozen) stor...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc. on behalf of the American Pharmacists Association.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834447/ https://www.ncbi.nlm.nih.gov/pubmed/33321139 http://dx.doi.org/10.1016/j.xphs.2020.12.006 |